ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ALLR Allarity Therapeutics Inc

0.5843
-0.0154 (-2.57%)
2024年5月25日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Allarity Therapeutics Inc ALLR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0154 -2.57% 0.5843 08:59:57
始値 安値 高値 終値 前日終値
0.60 0.561 0.601449 0.5758 0.5997
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2421:55EDGAR2Form 8-K/A - Current report: [Amend]
2024/5/2121:15EDGAR2Form 8-K - Current report
2024/5/2021:00GLOBEAllarity Therapeutics Regains Compliance with Nasdaq's..
2024/5/1805:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/1522:15EDGAR2Form 8-K - Current report
2024/5/1505:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1505:01GLOBEAllarity Therapeutics Reports First Quarter Financial..
2024/5/1000:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/0922:47EDGAR2Form 8-K - Current report
2024/5/0905:05EDGAR2Form RW - Registration Withdrawal Request
2024/5/0722:30GLOBEAllarity Therapeutics Announces that All Series A Preferred..
2024/5/0622:29EDGAR2Form 8-K - Current report
2024/5/0622:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/0621:00GLOBEAllarity Therapeutics Exceeds Nasdaq’s Minimum Equity..
2024/5/0221:00GLOBEAllarity Therapeutics’ Stenoparib Shows Clear Clinical..
2024/4/2920:00GLOBEAllarity Therapeutics Regains Compliance with NASDAQ Minimum..
2024/4/1722:10GLOBEAllarity Therapeutics Receives NASDAQ-Approved Extension to..
2024/4/0422:15GLOBEAllarity Therapeutics Announces 1-for-20 Reverse Stock Split
2024/3/2721:30GLOBEAllarity Therapeutics Makes Strategic Pivot to Focus Solely..
2024/3/2520:30GLOBEAllarity Therapeutics Receives Extension from Nasdaq..
2024/3/0822:38EDGAR2Form 8-K - Current report
2024/3/0821:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0821:15GLOBEAllarity Therapeutics Reports Full Year 2023 Financial..
2024/3/0811:45EDGAR2Form DEF 14A - Other definitive proxy statements
2024/3/0506:05EDGAR2Form 8-K - Current report
2024/3/0123:21EDGAR2Form 8-K - Current report
2024/2/2820:00GLOBEAllarity Therapeutics to Present at Biomarkers 2024
2024/2/2406:09EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
2024/2/1423:03EDGAR2Form 8-K - Current report
2024/2/0307:03EDGAR2Form D - Notice of Exempt Offering of Securities
2024/2/0206:40EDGAR2Form 8-K - Current report
2024/1/2707:07EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/1/2607:24EDGAR2Form 8-K - Current report
2024/1/2007:29EDGAR2Form 8-K - Current report
2023/12/1607:00EDGAR2Form S-1/A - General form for registration of securities..
2023/12/1220:00GLOBEAllarity Therapeutics Announces Thomas Jensen as Interim CEO..
2023/12/1120:30EDGAR2Form 8-K - Current report
2023/12/0707:00EDGAR2Form 8-K - Current report
2023/12/0622:30EDGAR2Form S-1/A - General form for registration of securities..
2023/12/0521:30EDGAR2Form 8-K - Current report
2023/12/0521:30GLOBEAllarity’s Early Phase 2 Stenoparib Data Indicates Clinical..
2023/11/1807:01EDGAR2Form 8-K - Current report
2023/11/1322:35EDGAR2Form 8-K - Current report
2023/11/0306:00EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/10/3122:30EDGAR2Form S-1 - General form for registration of securities under..
2023/10/3106:00EDGAR2Form 8-K - Current report
2023/10/2406:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/1806:00EDGAR2Form S-3/A - Registration statement under Securities Act of..
2023/10/1106:00EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/10/0220:00GLOBEAllarity Therapeutics to Present at Biomarkers Europe 2023

最近閲覧した銘柄

Delayed Upgrade Clock